She further explained: “That is why I recommended that they should only be prescribed following a multi-disciplinary assessment and within a research protocol.”
In addition, she expressed her support for the government’s decision, saying: “I support the Government’s decision.
To continue restrictions on the dispensing of puberty blockers for gender dysphoria outside the NHS where these essential safeguards are not being provided.”
The British Medical Association (BMA) stirred up controversy last year when it reacted negatively to the Cass Review’s findings, promising to “publicly critique”
The results and support transgender youngsters. The BMA said that “victimised” transgender youngsters will suffer as a result of the prohibition on puberty blockers.
